Renalytix Balance Sheet Health

Financial Health criteria checks 2/6

Renalytix has a total shareholder equity of $-11.1M and total debt of $9.3M, which brings its debt-to-equity ratio to -84.1%. Its total assets and total liabilities are $8.8M and $19.9M respectively.

Key information

-84.1%

Debt to equity ratio

US$9.34m

Debt

Interest coverage ration/a
CashUS$4.70m
Equity-US$11.11m
Total liabilitiesUS$19.88m
Total assetsUS$8.77m

Recent financial health updates

Recent updates

Renalytix: The Investment Case Is Shot

Jul 25

Renalytix AI GAAP EPS of -$0.20, revenue of $0.81M

Jun 30

Renalytix: High Growth Artificial Intelligence Play, Nearing A Possible Breakout

Apr 05

Renalytix: Laying The Foundations For Growth

Jan 05

Renalytix: Building Out A Capability To Ramp Revenue

Oct 20

Renalytix AI EPS beats by $0.06, misses on revenue

Jun 15

Centers for Medicaid & Medicare establishes MICT pathway

Jan 13

Exact and Exact Sciences trade higher; Seen as beneficiaries from new CMS rule

Jan 12

Renalytix AI EPS misses by $0.04

Nov 25

Financial Position Analysis

Short Term Liabilities: RNLX has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.

Long Term Liabilities: RNLX has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.


Debt to Equity History and Analysis

Debt Level: RNLX has negative shareholder equity, which is a more serious situation than a high debt level.

Reducing Debt: RNLX's has negative shareholder equity, so we do not need to check if its debt has reduced over time.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: RNLX has sufficient cash runway for 2 months based on last reported free cash flow, but has since raised additional capital.

Forecast Cash Runway: RNLX is forecast to have sufficient cash runway for 2 months based on free cash flow estimates, but has since raised additional capital.


Discover healthy companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.